- Latest gene therapy news
- Clinical trial databases
- Legislation and regulations
- Recent research articles
- Societies and more...

Home Patients Breaking news Clinical trials Conferences Articles Site map Contact
 
Menu
What is gene therapy
Gene Therapy news
Societies
Companies
Research institutes
Regulatory affairs
Clinical trial databases
Literature
 
 
Site Info

Time:




Best viewed at minimal screen resolution 1024x768
This website is hosted by Budget Webhosting Holland.

eXTReMe Tracker

Copyright © 2007, 2008 by Gene Therapy Net

 
 
Gene Therapy Research Institutes - US & Canada
Center for Cell and Gene Therapy, Baylor College of Medicine, Houston
Collaboration between Baylor College of Medicine, The Methodist Hospital and Texas Children's Hospital. Clinical research in the areas of stem cell transplantation, cellular therapy, and gene therapy.
Center for Gene Therapy, University of Michigan Medical Center, Ann Arbor
The Center fosters a multidisciplinary approach to new research as well as collaborative research endeavors in the area of gene therapy. The Vector Core manufactures several recombinant viral vectors.
Dep. of Gene and Cell Medicine, Mount Sinai School of Medicine, New York
The research is focused on various aspects of gene therapy, such as understanding basic virology, efficient gene delivery into the nucleus of cells, and incorporation of these genes into the genome.
Gene Therapy Center, University of Alabama, Birmingham
Dr. Curiel heads the center and is engaged in advancing the application of gene transfer methods for treatment of human disease. The efforts are focused on the development of improved vectors to accomplish targeted, cell-specific delivery.
Gene Therapy Center, University of North Carolina School of Medicine
Research in the laboratory has centered on the molecular biology of adeno-associated virus (AAV) in order to exploit the unique features of this virus to develop an efficient viral vector system for use in human gene therapy.
Harvard Gene Therapy Initiative, Harvard University, Boston
The Harvard Gene Therapy Initiative is headed by Dr. Richard Mulligan with the objective of promoting the use of gene therapy and to conduct research developing new gene delivery vector technologies.
Iowa Center for Gene Therapy, University of Iowa, Iowa City
Diseases of the lung, cardiovascular system, muscles, brain, and skin are focus areas of research as well as the development of gene therapy vectors and the identification of disease-causing genes.
MD Anderson Cancer Center, University of Texas, Houston
The major goals of the Innovative Cancer Therapies Program will be to enhance communication and collaboration among investigators and to develop new funding opportunities.
Minnesota University, Molecular and Cellular Therapeutics Program
The program has brought together regulatory, quality, product development, manufacturing and facilities engineering expertise to enable the translation of novel, experimental research into medicine for use in human clinical trials.
Penn Vector Core, University of Pennsylvania, Philadelphia
Penn Vector offers a variety of services associated with the development and production of both non-viral vectors and viral vectors including those derived from adeno-associated virus (AAV), adenovirus, and lentivirus.
Powell Gene Therapy Center, University of Florida, Gainesville
The primary mission is to merge molecular genetics research and health care delivery by developing new therapeutic strategies for the treatment of human diseases that involve gene transfer.
Tulane Center for Gene Therapy, Tulane University, New Orleans
The Center performs research characterizing adult stem cells, called mesenchymal stem cells or multipotential stromal cells (MSC) with a goal of using autologous adult stem cells for treating a variety of diseases.

Center for Gene Therapeutics, McMaster University, Hamilton, Canada
Research focused on the creation of vector systems for appropriate delivery of therapeutic genes for treatment of cancer, inflammatory diseases and infectious diseases.
 
 
 
Gene Therapy Research Institutes - Europe

Finland - A.I. Virtanen Institute of Molecular Medicine, University of Kuopio
The research is on cardiovascular diseases, neurodegenerative diseases, and metabolism-related diseases. Main target genes are vascular growth factors, and LDL receptor in cardiovascular area and cytotoxic genes in cancer therapy.

Israel - The Goldyne Savad Institiute of Gene Therapy, Hadassah, Jerusalem
Research covers a wide range of diseases along three main tracks: cellular gene therapy, viral vectors and non-viral vectors. The Institute is headed by Prof. Eithan Galun, M.D.
Netherlands - Oncogenomics VUmc, Amsterdam
The Gene Therapy research group aims to design new anti-cancer therapies using oncolytic adenoviruses and modulation of gene expression, with particular attention to the p53 tumor suppressor pathway.
Netherlands - Virus and Stem Cell Biology, Leiden
The group headed by Prof. Rob Hoeben performs basic research on viruses in order to develop efficient virus-derived gene-transfer vector. Current research centers around adenoviruses, lentiviruses, and reoviruses.
Netherlands - Therapeutic gene modulation, Groningen
The department is headed by Prof. Hidde Haisma and is focused on the development of drugs for the therapeutic manipulation of gene activity. The research is focused on cancer and inflammatory diseases.
Sweden - Molecular Medicine and Gene Therapy, Lund University
The laboratory investigates the properties of blood stem cells and is developing cell and gene therapy for blood disorders: Diamond-Blackfan Anemia and Gaucher Disease.
 
 
 
Gene Therapy Research Institutes - Australia
Centenary Institute of Cancer Medicine and Cell Biology, Sydney
Research is focussed on a combination of cancer, cell biology, molecular medicine and immunology. Research includes retroviral receptors, AAV gene transfer, novel retrovirus packaging cell lines, hemopoietic and mesenchymal stem cells.
Gene Therapy Research Unit, Children's Medical Research Unit
Research is focused on liver-targeted gene therapy, nerve and muscle diseases, Cystic Fibrosis and gene therapy for the prevention of malaria.
Your research institute not listed? Click here to add
 
 
 
European Union Framework Programme Six (FP6) Integrated Projects

FP6 is the European Community Framework Programme for Research, Technological Development and Demonstration. It is a collection of the actions at EU level to fund and promote research.

Attack: Adoptive engineered T cell Targeting to Activate Cancer Killing, to improve T cell mediated immunotherapy to fight a broad range of cancer
Clinigene: European Network for the Advancement of Clinical Gene Transfer and Therapy
Consert: consortium of European research and clinical institutions cooperating to develop gene therapy for inherited diseases
EPI-vector consortium to develop episomal vectors as gene delivery systems for therapeutic application
GIANT: Gene Therapy, an integrated approach to neoplastic treatment, gene therapy for the treatment of prostate cancer
Improved precision of Cystic Fibrosis therapy, a project investigating a new approach to the gene therapy of cystic fibrosis
Tumor-Host Genomics, a concerted effort to understand tumor-host interactions, and to identify novel therapeutic targets
 
 
 
Information

Overview of research institutes, centers and universities involved in pre-clinical and clinical gene therapy research:
- US & Canada
- Europe
- Australia

Check here also the European Union Framework Programme Six (FP6) Integrated Projects, such as Attack, Clinigene, Consert and GIANT.

 
 
Gene Therapy News
Selected Google news items
Read here more breaking news

RSS source Google news